| Issue Date | Title | Author(s) |
| 2018 | Could the Unidentified Bright Objects in Children be Accepted as an Additional Diagnostic Criterion for Neurofibromatosis Type-1? | Ince, D.; Erdem, M.; Kizmazoglu, D.; Sarioglu, F. C.; Ozdogar, M. B.; Baysal, B.; Mutafoğlu, Kamer |
| 2018 | Dokuz Eylul University Pediatric Oncology Group: Ewing Sarcoma Family of Tumors Experience | Ince, D.; Kizmazoglu, D.; Erdem, M.; Cecen, E.; Baysal, B.; Cetingoz, R.; Demiral, A. |
| 2018 | Evaluation of Ototoxicity in Children with Head and Neck Cancer who Received Cisplatin and/or Carboplatin During Treatment | Olgun, Y.; Ince, D.; Kizmazoglu, D.; Erdem, M.; Kirkim, G.; Demiral, A.; Mutafoğlu, Kamer |
| 2018 | Localized Neuroblastoma: The 30 Years Experience of Dokuz Eylul University | Ince, D.; Kizmazoglu, D.; Cecen, E.; Erdem, M.; Altun, Z.; Aktas, S.; Olguner, M. |
| 2018 | A single center experience of pediatric Hodgkin lymphoma [p. 102] | Ince, D.; Erdem, M.; Kizmazoglu, D.; Cecen, E.; Demiral, A.; Cetingoz, R.; Ozer, E. |
| 2018 | A Single Center Experience of Pediatric Hodgkin Lymphoma [pp. 201-202] | Ince, D.; Erdem, M.; Kizmazoglu, D.; Cecen, E.; Demiral, A.; Cetingoz, R.; Ozer, E. |
| 2018 | Treatment of Children with Intermediate-Risk Neuroblastoma: Dokuz Eylul University Experience | Ince, D.; Erdem, M.; Kizmazoglu, D.; Cecen, E.; Aktas, S.; Altun, Z.; Demiral, A. |
| 2018 | Treatment of Neuroblastoma in Infants Younger than 18 Months: The 30 Years Experience of Dokuz Eylul University | Ince, D.; Kizmazoglu, D.; Erdem, M.; Aktas, S.; Cecen, E.; Altun, Z.; Demiral, A. |
